Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Peripheral Blood Stem Cell Transplantation × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Myelodysplastic Syndromes 15 Multiple Myeloma 9 Leukemia, Myelomonocytic, Chronic 9 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Anemia, Refractory, with Excess of Blasts 8 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Leukemia, Biphenotypic, Acute 7 Hodgkin Disease 7 Primary Myelofibrosis 6 Lymphoma 6 Leukemia 6 Burkitt Lymphoma 6 Lymphoma, T-Cell 5 Lymphoma, Mantle-Cell 5 Anemia, Aplastic 5 Neoplasms 4 Leukemia, Myeloid 4 Leukemia, Lymphoid 4 Hematologic Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precancerous Conditions 3 Polycythemia Vera 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Myeloid, Accelerated Phase 3

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡